CTKB Cytek Biosciences
- 5.385
- +0.185+3.56%
Cytek Biosciences News
Cytek Biosciences | 4: Statement of changes in beneficial ownership of securities-Officer Jiang Wenbin
Cytek Biosciences | 4: Statement of changes in beneficial ownership of securities-Director Holder Michael
Cytek Biosciences | 4: Statement of changes in beneficial ownership of securities-Officer Barnett Valerie
Cytek Biosciences | 4: Statement of changes in beneficial ownership of securities-Officer Jiang Wenbin
Cytek Biosciences | 4: Statement of changes in beneficial ownership of securities-Officer Yan Ming
Cytek Biosciences | 4: Statement of changes in beneficial ownership of securities-Officer Williams Paul Christopher
Cytek Biosciences | 4: Statement of changes in beneficial ownership of securities-Officer Poirson Allen
Cytek Biosciences | 4: Statement of changes in beneficial ownership of securities-Officer Busque Philippe
Cytek Biosciences | 4: Statement of changes in beneficial ownership of securities-Director Holder Michael
Cytek Biosciences | 3: Initial statement of beneficial ownership of securities-Director Holder Michael
Cytek Biosciences | 4: Statement of changes in beneficial ownership of securities-Director Ball Jack
Cytek Biosciences | 4: Statement of changes in beneficial ownership of securities-Director NEFF DEBORAH J
Cytek Biosciences | 4: Statement of changes in beneficial ownership of securities-Director Imper Vera
Cytek Biosciences | 4: Statement of changes in beneficial ownership of securities-Director HARDISON DON M
Cytek Biosciences | 4: Statement of changes in beneficial ownership of securities-Officer Poirson Allen
Cytek Biosciences | 4: Statement of changes in beneficial ownership of securities-Officer Yan Ming
Cytek Biosciences | 4: Statement of changes in beneficial ownership of securities-Officer Williams Paul Christopher
Cytek Biosciences | 4: Statement of changes in beneficial ownership of securities-Officer Jiang Wenbin
Cytek Biosciences | 4: Statement of changes in beneficial ownership of securities-Officer Barnett Valerie
Cytek Biosciences | 4: Statement of changes in beneficial ownership of securities-Officer Busque Philippe
Analysis
Price Target
No Data
No Data